Global Flow Cytometry in Oncology Supply, Demand and Key Producers, 2023-2029

Description

The global Flow Cytometry in Oncology market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Among the clinical uses of flow cytometry cancer represents one of the most relevant. Several applications of flow cytometry can currently be applied to the study of cancer, including the detection of tumour cell DNA aneuploidy, the analysis of tumour cell proliferation and the immunophenotyping of leukemias.

This report studies the global Flow Cytometry in Oncology demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Flow Cytometry in Oncology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Flow Cytometry in Oncology that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Flow Cytometry in Oncology total market, 2018-2029, (USD Million)
Global Flow Cytometry in Oncology total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Flow Cytometry in Oncology total market, key domestic companies and share, (USD Million)
Global Flow Cytometry in Oncology revenue by player and market share 2018-2023, (USD Million)
Global Flow Cytometry in Oncology total market by Type, CAGR, 2018-2029, (USD Million)
Global Flow Cytometry in Oncology total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Flow Cytometry in Oncology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioAffinity Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation Cytek Biosciences, Cytognos, S.L., Danaher Corporation and Miltenyi Biotec B.V. and Co. KG, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Flow Cytometry in Oncology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Flow Cytometry in Oncology Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Flow Cytometry in Oncology Market, Segmentation by Type
    Assays and Kits
    Instruments
    Reagents and Consumables
    Software

Global Flow Cytometry in Oncology Market, Segmentation by Application
    Diagnostic Laboratories
    Hospitals and Healthcare Centers
    Academic and Research Institutions
    Others

Companies Profiled:
    Agilent Technologies, Inc.
    Apogee Flow Systems Ltd.
    Becton, Dickinson and Company
    bioAffinity Technologies, Inc.
    Bio-Rad Laboratories, Inc.
    Bio-Techne Corporation Cytek Biosciences
    Cytognos, S.L.
    Danaher Corporation
    Miltenyi Biotec B.V. and Co. KG
    Laboratory Corporation of America Holdings
    Luminex Corporation
    NeoGenomics Laboratories, Inc.
    Sony Corporation
    Thermo Fisher Scientific Inc

Key Questions Answered
1. How big is the global Flow Cytometry in Oncology market?
2. What is the demand of the global Flow Cytometry in Oncology market?
3. What is the year over year growth of the global Flow Cytometry in Oncology market?
4. What is the total value of the global Flow Cytometry in Oncology market?
5. Who are the major players in the global Flow Cytometry in Oncology market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Flow Cytometry in Oncology Introduction
    1.2 World Flow Cytometry in Oncology Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Flow Cytometry in Oncology Total Market by Region (by Headquarter Location)
        1.3.1 World Flow Cytometry in Oncology Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Flow Cytometry in Oncology Market Size (2018-2029)
        1.3.3 China Flow Cytometry in Oncology Market Size (2018-2029)
        1.3.4 Europe Flow Cytometry in Oncology Market Size (2018-2029)
        1.3.5 Japan Flow Cytometry in Oncology Market Size (2018-2029)
        1.3.6 South Korea Flow Cytometry in Oncology Market Size (2018-2029)
        1.3.7 ASEAN Flow Cytometry in Oncology Market Size (2018-2029)
        1.3.8 India Flow Cytometry in Oncology Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Flow Cytometry in Oncology Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Flow Cytometry in Oncology Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Flow Cytometry in Oncology Consumption Value (2018-2029)
    2.2 World Flow Cytometry in Oncology Consumption Value by Region
        2.2.1 World Flow Cytometry in Oncology Consumption Value by Region (2018-2023)
        2.2.2 World Flow Cytometry in Oncology Consumption Value Forecast by Region (2024-2029)
    2.3 United States Flow Cytometry in Oncology Consumption Value (2018-2029)
    2.4 China Flow Cytometry in Oncology Consumption Value (2018-2029)
    2.5 Europe Flow Cytometry in Oncology Consumption Value (2018-2029)
    2.6 Japan Flow Cytometry in Oncology Consumption Value (2018-2029)
    2.7 South Korea Flow Cytometry in Oncology Consumption Value (2018-2029)
    2.8 ASEAN Flow Cytometry in Oncology Consumption Value (2018-2029)
    2.9 India Flow Cytometry in Oncology Consumption Value (2018-2029)

3 World Flow Cytometry in Oncology Companies Competitive Analysis
    3.1 World Flow Cytometry in Oncology Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Flow Cytometry in Oncology Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Flow Cytometry in Oncology in 2022
        3.2.3 Global Concentration Ratios (CR8) for Flow Cytometry in Oncology in 2022
    3.3 Flow Cytometry in Oncology Company Evaluation Quadrant
    3.4 Flow Cytometry in Oncology Market: Overall Company Footprint Analysis
        3.4.1 Flow Cytometry in Oncology Market: Region Footprint
        3.4.2 Flow Cytometry in Oncology Market: Company Product Type Footprint
        3.4.3 Flow Cytometry in Oncology Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Flow Cytometry in Oncology Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Flow Cytometry in Oncology Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Flow Cytometry in Oncology Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Flow Cytometry in Oncology Consumption Value Comparison
        4.2.1 United States VS China: Flow Cytometry in Oncology Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Flow Cytometry in Oncology Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Flow Cytometry in Oncology Companies and Market Share, 2018-2023
        4.3.1 United States Based Flow Cytometry in Oncology Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Flow Cytometry in Oncology Revenue, (2018-2023)
    4.4 China Based Companies Flow Cytometry in Oncology Revenue and Market Share, 2018-2023
        4.4.1 China Based Flow Cytometry in Oncology Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Flow Cytometry in Oncology Revenue, (2018-2023)
    4.5 Rest of World Based Flow Cytometry in Oncology Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Flow Cytometry in Oncology Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Flow Cytometry in Oncology Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Flow Cytometry in Oncology Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Assays and Kits
        5.2.2 Instruments
        5.2.3 Reagents and Consumables
        5.2.4 Software
    5.3 Market Segment by Type
        5.3.1 World Flow Cytometry in Oncology Market Size by Type (2018-2023)
        5.3.2 World Flow Cytometry in Oncology Market Size by Type (2024-2029)
        5.3.3 World Flow Cytometry in Oncology Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Flow Cytometry in Oncology Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Diagnostic Laboratories
        6.2.2 Hospitals and Healthcare Centers
        6.2.3 Academic and Research Institutions
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Flow Cytometry in Oncology Market Size by Application (2018-2023)
        6.3.2 World Flow Cytometry in Oncology Market Size by Application (2024-2029)
        6.3.3 World Flow Cytometry in Oncology Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Agilent Technologies, Inc.
        7.1.1 Agilent Technologies, Inc. Details
        7.1.2 Agilent Technologies, Inc. Major Business
        7.1.3 Agilent Technologies, Inc. Flow Cytometry in Oncology Product and Services
        7.1.4 Agilent Technologies, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Agilent Technologies, Inc. Recent Developments/Updates
        7.1.6 Agilent Technologies, Inc. Competitive Strengths & Weaknesses
    7.2 Apogee Flow Systems Ltd.
        7.2.1 Apogee Flow Systems Ltd. Details
        7.2.2 Apogee Flow Systems Ltd. Major Business
        7.2.3 Apogee Flow Systems Ltd. Flow Cytometry in Oncology Product and Services
        7.2.4 Apogee Flow Systems Ltd. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Apogee Flow Systems Ltd. Recent Developments/Updates
        7.2.6 Apogee Flow Systems Ltd. Competitive Strengths & Weaknesses
    7.3 Becton, Dickinson and Company
        7.3.1 Becton, Dickinson and Company Details
        7.3.2 Becton, Dickinson and Company Major Business
        7.3.3 Becton, Dickinson and Company Flow Cytometry in Oncology Product and Services
        7.3.4 Becton, Dickinson and Company Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Becton, Dickinson and Company Recent Developments/Updates
        7.3.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
    7.4 bioAffinity Technologies, Inc.
        7.4.1 bioAffinity Technologies, Inc. Details
        7.4.2 bioAffinity Technologies, Inc. Major Business
        7.4.3 bioAffinity Technologies, Inc. Flow Cytometry in Oncology Product and Services
        7.4.4 bioAffinity Technologies, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 bioAffinity Technologies, Inc. Recent Developments/Updates
        7.4.6 bioAffinity Technologies, Inc. Competitive Strengths & Weaknesses
    7.5 Bio-Rad Laboratories, Inc.
        7.5.1 Bio-Rad Laboratories, Inc. Details
        7.5.2 Bio-Rad Laboratories, Inc. Major Business
        7.5.3 Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Product and Services
        7.5.4 Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
        7.5.6 Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
    7.6 Bio-Techne Corporation Cytek Biosciences
        7.6.1 Bio-Techne Corporation Cytek Biosciences Details
        7.6.2 Bio-Techne Corporation Cytek Biosciences Major Business
        7.6.3 Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Product and Services
        7.6.4 Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Bio-Techne Corporation Cytek Biosciences Recent Developments/Updates
        7.6.6 Bio-Techne Corporation Cytek Biosciences Competitive Strengths & Weaknesses
    7.7 Cytognos, S.L.
        7.7.1 Cytognos, S.L. Details
        7.7.2 Cytognos, S.L. Major Business
        7.7.3 Cytognos, S.L. Flow Cytometry in Oncology Product and Services
        7.7.4 Cytognos, S.L. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Cytognos, S.L. Recent Developments/Updates
        7.7.6 Cytognos, S.L. Competitive Strengths & Weaknesses
    7.8 Danaher Corporation
        7.8.1 Danaher Corporation Details
        7.8.2 Danaher Corporation Major Business
        7.8.3 Danaher Corporation Flow Cytometry in Oncology Product and Services
        7.8.4 Danaher Corporation Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Danaher Corporation Recent Developments/Updates
        7.8.6 Danaher Corporation Competitive Strengths & Weaknesses
    7.9 Miltenyi Biotec B.V. and Co. KG
        7.9.1 Miltenyi Biotec B.V. and Co. KG Details
        7.9.2 Miltenyi Biotec B.V. and Co. KG Major Business
        7.9.3 Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Product and Services
        7.9.4 Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Miltenyi Biotec B.V. and Co. KG Recent Developments/Updates
        7.9.6 Miltenyi Biotec B.V. and Co. KG Competitive Strengths & Weaknesses
    7.10 Laboratory Corporation of America Holdings
        7.10.1 Laboratory Corporation of America Holdings Details
        7.10.2 Laboratory Corporation of America Holdings Major Business
        7.10.3 Laboratory Corporation of America Holdings Flow Cytometry in Oncology Product and Services
        7.10.4 Laboratory Corporation of America Holdings Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Laboratory Corporation of America Holdings Recent Developments/Updates
        7.10.6 Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
    7.11 Luminex Corporation
        7.11.1 Luminex Corporation Details
        7.11.2 Luminex Corporation Major Business
        7.11.3 Luminex Corporation Flow Cytometry in Oncology Product and Services
        7.11.4 Luminex Corporation Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Luminex Corporation Recent Developments/Updates
        7.11.6 Luminex Corporation Competitive Strengths & Weaknesses
    7.12 NeoGenomics Laboratories, Inc.
        7.12.1 NeoGenomics Laboratories, Inc. Details
        7.12.2 NeoGenomics Laboratories, Inc. Major Business
        7.12.3 NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Product and Services
        7.12.4 NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 NeoGenomics Laboratories, Inc. Recent Developments/Updates
        7.12.6 NeoGenomics Laboratories, Inc. Competitive Strengths & Weaknesses
    7.13 Sony Corporation
        7.13.1 Sony Corporation Details
        7.13.2 Sony Corporation Major Business
        7.13.3 Sony Corporation Flow Cytometry in Oncology Product and Services
        7.13.4 Sony Corporation Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Sony Corporation Recent Developments/Updates
        7.13.6 Sony Corporation Competitive Strengths & Weaknesses
    7.14 Thermo Fisher Scientific Inc
        7.14.1 Thermo Fisher Scientific Inc Details
        7.14.2 Thermo Fisher Scientific Inc Major Business
        7.14.3 Thermo Fisher Scientific Inc Flow Cytometry in Oncology Product and Services
        7.14.4 Thermo Fisher Scientific Inc Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Thermo Fisher Scientific Inc Recent Developments/Updates
        7.14.6 Thermo Fisher Scientific Inc Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Flow Cytometry in Oncology Industry Chain
    8.2 Flow Cytometry in Oncology Upstream Analysis
    8.3 Flow Cytometry in Oncology Midstream Analysis
    8.4 Flow Cytometry in Oncology Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Flow Cytometry in Oncology Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Flow Cytometry in Oncology Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Flow Cytometry in Oncology Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Flow Cytometry in Oncology Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Flow Cytometry in Oncology Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Flow Cytometry in Oncology Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Flow Cytometry in Oncology Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Flow Cytometry in Oncology Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Flow Cytometry in Oncology Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Flow Cytometry in Oncology Players in 2022
    Table 12. World Flow Cytometry in Oncology Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Flow Cytometry in Oncology Company Evaluation Quadrant
    Table 14. Head Office of Key Flow Cytometry in Oncology Player
    Table 15. Flow Cytometry in Oncology Market: Company Product Type Footprint
    Table 16. Flow Cytometry in Oncology Market: Company Product Application Footprint
    Table 17. Flow Cytometry in Oncology Mergers & Acquisitions Activity
    Table 18. United States VS China Flow Cytometry in Oncology Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Flow Cytometry in Oncology Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Flow Cytometry in Oncology Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Flow Cytometry in Oncology Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Flow Cytometry in Oncology Revenue Market Share (2018-2023)
    Table 23. China Based Flow Cytometry in Oncology Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Flow Cytometry in Oncology Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Flow Cytometry in Oncology Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Flow Cytometry in Oncology Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Flow Cytometry in Oncology Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Flow Cytometry in Oncology Revenue Market Share (2018-2023)
    Table 29. World Flow Cytometry in Oncology Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Flow Cytometry in Oncology Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Flow Cytometry in Oncology Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Flow Cytometry in Oncology Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Flow Cytometry in Oncology Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Flow Cytometry in Oncology Market Size by Application (2024-2029) & (USD Million)
    Table 35. Agilent Technologies, Inc. Basic Information, Area Served and Competitors
    Table 36. Agilent Technologies, Inc. Major Business
    Table 37. Agilent Technologies, Inc. Flow Cytometry in Oncology Product and Services
    Table 38. Agilent Technologies, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Agilent Technologies, Inc. Recent Developments/Updates
    Table 40. Agilent Technologies, Inc. Competitive Strengths & Weaknesses
    Table 41. Apogee Flow Systems Ltd. Basic Information, Area Served and Competitors
    Table 42. Apogee Flow Systems Ltd. Major Business
    Table 43. Apogee Flow Systems Ltd. Flow Cytometry in Oncology Product and Services
    Table 44. Apogee Flow Systems Ltd. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Apogee Flow Systems Ltd. Recent Developments/Updates
    Table 46. Apogee Flow Systems Ltd. Competitive Strengths & Weaknesses
    Table 47. Becton, Dickinson and Company Basic Information, Area Served and Competitors
    Table 48. Becton, Dickinson and Company Major Business
    Table 49. Becton, Dickinson and Company Flow Cytometry in Oncology Product and Services
    Table 50. Becton, Dickinson and Company Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Becton, Dickinson and Company Recent Developments/Updates
    Table 52. Becton, Dickinson and Company Competitive Strengths & Weaknesses
    Table 53. bioAffinity Technologies, Inc. Basic Information, Area Served and Competitors
    Table 54. bioAffinity Technologies, Inc. Major Business
    Table 55. bioAffinity Technologies, Inc. Flow Cytometry in Oncology Product and Services
    Table 56. bioAffinity Technologies, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. bioAffinity Technologies, Inc. Recent Developments/Updates
    Table 58. bioAffinity Technologies, Inc. Competitive Strengths & Weaknesses
    Table 59. Bio-Rad Laboratories, Inc. Basic Information, Area Served and Competitors
    Table 60. Bio-Rad Laboratories, Inc. Major Business
    Table 61. Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Product and Services
    Table 62. Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Bio-Rad Laboratories, Inc. Recent Developments/Updates
    Table 64. Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
    Table 65. Bio-Techne Corporation Cytek Biosciences Basic Information, Area Served and Competitors
    Table 66. Bio-Techne Corporation Cytek Biosciences Major Business
    Table 67. Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Product and Services
    Table 68. Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Bio-Techne Corporation Cytek Biosciences Recent Developments/Updates
    Table 70. Bio-Techne Corporation Cytek Biosciences Competitive Strengths & Weaknesses
    Table 71. Cytognos, S.L. Basic Information, Area Served and Competitors
    Table 72. Cytognos, S.L. Major Business
    Table 73. Cytognos, S.L. Flow Cytometry in Oncology Product and Services
    Table 74. Cytognos, S.L. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Cytognos, S.L. Recent Developments/Updates
    Table 76. Cytognos, S.L. Competitive Strengths & Weaknesses
    Table 77. Danaher Corporation Basic Information, Area Served and Competitors
    Table 78. Danaher Corporation Major Business
    Table 79. Danaher Corporation Flow Cytometry in Oncology Product and Services
    Table 80. Danaher Corporation Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Danaher Corporation Recent Developments/Updates
    Table 82. Danaher Corporation Competitive Strengths & Weaknesses
    Table 83. Miltenyi Biotec B.V. and Co. KG Basic Information, Area Served and Competitors
    Table 84. Miltenyi Biotec B.V. and Co. KG Major Business
    Table 85. Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Product and Services
    Table 86. Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Miltenyi Biotec B.V. and Co. KG Recent Developments/Updates
    Table 88. Miltenyi Biotec B.V. and Co. KG Competitive Strengths & Weaknesses
    Table 89. Laboratory Corporation of America Holdings Basic Information, Area Served and Competitors
    Table 90. Laboratory Corporation of America Holdings Major Business
    Table 91. Laboratory Corporation of America Holdings Flow Cytometry in Oncology Product and Services
    Table 92. Laboratory Corporation of America Holdings Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Laboratory Corporation of America Holdings Recent Developments/Updates
    Table 94. Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
    Table 95. Luminex Corporation Basic Information, Area Served and Competitors
    Table 96. Luminex Corporation Major Business
    Table 97. Luminex Corporation Flow Cytometry in Oncology Product and Services
    Table 98. Luminex Corporation Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Luminex Corporation Recent Developments/Updates
    Table 100. Luminex Corporation Competitive Strengths & Weaknesses
    Table 101. NeoGenomics Laboratories, Inc. Basic Information, Area Served and Competitors
    Table 102. NeoGenomics Laboratories, Inc. Major Business
    Table 103. NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Product and Services
    Table 104. NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. NeoGenomics Laboratories, Inc. Recent Developments/Updates
    Table 106. NeoGenomics Laboratories, Inc. Competitive Strengths & Weaknesses
    Table 107. Sony Corporation Basic Information, Area Served and Competitors
    Table 108. Sony Corporation Major Business
    Table 109. Sony Corporation Flow Cytometry in Oncology Product and Services
    Table 110. Sony Corporation Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Sony Corporation Recent Developments/Updates
    Table 112. Thermo Fisher Scientific Inc Basic Information, Area Served and Competitors
    Table 113. Thermo Fisher Scientific Inc Major Business
    Table 114. Thermo Fisher Scientific Inc Flow Cytometry in Oncology Product and Services
    Table 115. Thermo Fisher Scientific Inc Flow Cytometry in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 116. Global Key Players of Flow Cytometry in Oncology Upstream (Raw Materials)
    Table 117. Flow Cytometry in Oncology Typical Customers
List of Figure
    Figure 1. Flow Cytometry in Oncology Picture
    Figure 2. World Flow Cytometry in Oncology Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Flow Cytometry in Oncology Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Flow Cytometry in Oncology Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Flow Cytometry in Oncology Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Flow Cytometry in Oncology Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Flow Cytometry in Oncology Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Flow Cytometry in Oncology Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Flow Cytometry in Oncology Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Flow Cytometry in Oncology Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Flow Cytometry in Oncology Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Flow Cytometry in Oncology Revenue (2018-2029) & (USD Million)
    Figure 13. Flow Cytometry in Oncology Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Flow Cytometry in Oncology Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Flow Cytometry in Oncology Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Flow Cytometry in Oncology by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Flow Cytometry in Oncology Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Flow Cytometry in Oncology Markets in 2022
    Figure 27. United States VS China: Flow Cytometry in Oncology Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Flow Cytometry in Oncology Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Flow Cytometry in Oncology Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Flow Cytometry in Oncology Market Size Market Share by Type in 2022
    Figure 31. Assays and Kits
    Figure 32. Instruments
    Figure 33. Reagents and Consumables
    Figure 34. Software
    Figure 35. World Flow Cytometry in Oncology Market Size Market Share by Type (2018-2029)
    Figure 36. World Flow Cytometry in Oncology Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Flow Cytometry in Oncology Market Size Market Share by Application in 2022
    Figure 38. Diagnostic Laboratories
    Figure 39. Hospitals and Healthcare Centers
    Figure 40. Academic and Research Institutions
    Figure 41. Others
    Figure 42. Flow Cytometry in Oncology Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source